The glycosylation site occupancy of IgA1[127–153] and IgG2[172–180] exhibited no significant changes in the progression of HBV-HCC, and which of IgA1[332–353] was decreased in CHB compared to HC (Fig. 8F). Here, IGHA1 is linked to hepatocellular carcinoma.